Literature DB >> 30615845

Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis.

Stephanie A Fong1, Amanda J Drilling1, Mian Li Ooi1, Sathish Paramasivan1, John W Finnie2, Sandra Morales3, Alkis J Psaltis1, Sarah Vreugde1, Peter-John Wormald4.   

Abstract

Pseudomonas aeruginosa (PA) is a bacterial pathogen that frequently displays antibiotic resistance. Its presence within the sinuses of chronic rhinosinusitis sufferers is associated with poorer quality of life. Obligately lytic bacteriophages (phages) are viruses that infect, replicate within, and lyse bacteria, causing bacterial death. The aims of this study were to assess the safety and efficacy of a PA phage cocktail (CT-PA) in a sheep model of rhinosinusitis. The sheep rhinosinusitis model was adapted to simulate PA infection in sheep frontal sinuses. To assess efficacy, after a 7-day biofilm formation period, sheep received twice-daily frontal trephine flushes of CT-PA or saline for 1 week. Biofilm quantitation on frontal sinus mucosa was performed using LIVE/DEAD BacLight staining. To assess safety, sheep received twice-daily frontal trephine flushes of CT-PA or vehicle control for 3 weeks. Blood and fecal samples were collected throughout treatment. Histopathology of frontal sinus, lung, heart, liver, spleen, and kidney tissue was performed. Sinus cilia were visualized using scanning electron microscopy (SEM). The Efficacy arm showed a statistically significant reduction in biofilm biomass with all concentrations of CT-PA tested (P < 0.05). Phage presence in sinuses was maintained for at least 16hours after the final flush. All Safety arm sheep completed 3 weeks of treatment. Phage was detected consistently in feces and sporadically in blood and organ samples. Histology and SEM of tissues revealed no treatment-related damage. In conclusion, CT-PA was able to decrease sinus PA biofilm at concentrations of 108-1010 PFU/mL. No safety concerns were noted.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30615845     DOI: 10.1016/j.trsl.2018.12.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  10 in total

Review 1.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

Review 2.  Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review.

Authors:  Samuel J M Hale; Brett Wagner Mackenzie; Christian A Lux; Kristi Biswas; Raymond Kim; Richard G Douglas
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

3.  APTC-C-SA01: A Novel Bacteriophage Cocktail Targeting Staphylococcus aureus and MRSA Biofilms.

Authors:  Sha Liu; Karen Hon; George Spyro Bouras; Alkis James Psaltis; Keith Shearwin; Peter-John Wormald; Sarah Vreugde
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

4.  Detection of virulence and multidrug resistance operons in Pseudomonas aeruginosa isolated from Egyptian Baladi sheep and goat.

Authors:  A N Dapgh; A S Hakim; H A Abouelhag; A M Abdou; E A Elgabry
Journal:  Vet World       Date:  2019-10-04

5.  Exacerbations of Chronic Rhinosinusitis-Microbiology and Perspectives of Phage Therapy.

Authors:  Joanna Szaleniec; Agnieszka Gibała; Monika Pobiega; Sylwia Parasion; Jacek Składzień; Paweł Stręk; Tomasz Gosiewski; Maciej Szaleniec
Journal:  Antibiotics (Basel)       Date:  2019-10-05

6.  Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella in the Food Chain.

Authors:  Ewelina A Wójcik; Małgorzata Stańczyk; Arkadiusz Wojtasik; Justyna D Kowalska; Magdalena Nowakowska; Magdalena Łukasiak; Milena Bartnicka; Joanna Kazimierczak; Jarosław Dastych
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.048

Review 7.  Bacteriophage - A Promising Alternative Measure for Bacterial Biofilm Control.

Authors:  Fengjuan Tian; Jing Li; Amina Nazir; Yigang Tong
Journal:  Infect Drug Resist       Date:  2021-01-20       Impact factor: 4.003

Review 8.  Phage therapeutics: from promises to practices and prospectives.

Authors:  Kanika Bhargava; Gopal Nath; Amit Bhargava; G K Aseri; Neelam Jain
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-25       Impact factor: 4.813

Review 9.  Phages in Food Industry Biocontrol and Bioremediation.

Authors:  Pablo Cristobal-Cueto; Alberto García-Quintanilla; Jaime Esteban; Meritxell García-Quintanilla
Journal:  Antibiotics (Basel)       Date:  2021-06-28

Review 10.  The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.

Authors:  Dan Liu; Jonas D Van Belleghem; Christiaan R de Vries; Elizabeth Burgener; Qingquan Chen; Robert Manasherob; Jenny R Aronson; Derek F Amanatullah; Pranita D Tamma; Gina A Suh
Journal:  Viruses       Date:  2021-06-29       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.